Operating Income (Loss) in USD of International Stem Cell CORP from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
International Stem Cell CORP quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • International Stem Cell CORP Operating Income (Loss) for the quarter ending 30 Sep 2025 was $94K.
  • International Stem Cell CORP Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $97K.
  • International Stem Cell CORP annual Operating Income (Loss) for 2024 was -$68K, a 89.7% increase from 2023.
  • International Stem Cell CORP annual Operating Income (Loss) for 2023 was -$663K, a 262% decline from 2022.
  • International Stem Cell CORP annual Operating Income (Loss) for 2022 was -$183K, a 90.5% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

International Stem Cell CORP Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $97K $94K +$184K 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 -$87K $167K +$18K +12.1% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 -$105K -$215K -$37K -20.8% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 -$68K $51K +$475K 01 Oct 2024 31 Dec 2024 10-K 28 Mar 2025
Q3 2024 -$543K -$90K +$7K +7.22% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 -$550K $149K +$293K 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 -$843K -$178K -$180K 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 -$663K -$424K -$485K -795% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2025
Q3 2023 -$178K -$97K +$203K +67.7% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 -$381K -$144K -$175K -565% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 -$206K $2K* -$23K 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 -$183K $61K +$386K 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 -$569K -$300K +$323K +51.8% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$892K $31K +$437K 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023
Q1 2022 -$1.33M $25K +$592K 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 -$1.92M -$325K +$408K +55.7% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 -$2.33M -$623K +$175K +21.9% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$2.5M -$406K +$426K +51.2% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 -$2.93M -$567K -$112K -24.6% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022
Q4 2020 -$2.82M -$733K +$1.75M +70.5% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022
Q3 2020 -$4.57M -$798K +$15K +1.85% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$4.59M -$832K +$109K +11.6% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 -$4.69M -$455K +$1.03M +69.4% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q4 2019 -$5.73M -$2.49M -$1.23M -97.4% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2021
Q3 2019 -$4.5M -$813K -$150K -22.6% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 -$4.35M -$941K -$574K -156% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020
Q1 2019 -$3.78M -$1.49M -$304K -25.7% 01 Jan 2019 31 Mar 2019 10-Q 19 Jun 2020
Q4 2018 -$3.47M -$1.26M +$665K +34.6% 01 Oct 2018 31 Dec 2018 10-K 01 Jun 2020
Q3 2018 -$4.14M -$663K +$307K +31.6% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 -$4.45M -$367K +$635K +63.4% 01 Apr 2018 30 Jun 2018 10-Q 27 Aug 2019
Q1 2018 -$5.08M -$1.19M -$139K -13.3% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 -$4.94M -$1.92M -$751K -64% 01 Oct 2017 31 Dec 2017 10-K 15 Apr 2019
Q3 2017 -$4.19M -$970K +$292K +23.1% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$4.48M -$1M +$247K +19.8% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 -$4.73M -$1.05M +$121K +10.4% 01 Jan 2017 31 Mar 2017 10-Q 21 May 2018
Q4 2016 -$4.85M -$1.17M -$134K -12.9% 01 Oct 2016 31 Dec 2016 10-K 09 Apr 2018
Q3 2016 -$4.72M -$1.26M -$640K -103% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$4.08M -$1.25M -$312K -33.3% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q1 2016 -$3.77M -$1.17M +$799K +40.6% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$4.56M -$1.04M +$1.3M +55.6% 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 -$5.86M -$622K +$1.41M +69.4% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 -$7.28M -$937K +$1.31M +58.2% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q1 2015 -$8.58M -$1.97M +$99K +4.79% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016
Q4 2014 -$8.68M -$2.34M -$398K -20.5% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016
Q3 2014 -$8.28M -$2.03M -$331K -19.4% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015
Q2 2014 -$7.95M -$2.24M -$53K -2.42% 01 Apr 2014 30 Jun 2014 10-Q 13 Aug 2015
Q1 2014 -$7.9M -$2.07M -$352K -20.5% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q4 2013 -$7.55M -$1.94M +$651K +25.1% 01 Oct 2013 31 Dec 2013 10-K 30 Mar 2015
Q3 2013 -$8.2M -$1.7M +$377K +18.1% 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014
Q2 2013 -$8.57M -$2.19M +$235K +9.69% 01 Apr 2013 30 Jun 2013 10-Q 08 Aug 2014
Q1 2013 -$8.81M -$1.71M +$1.01M +37% 01 Jan 2013 31 Mar 2013 10-Q 13 May 2014
Q4 2012 -$9.82M -$2.59M +$315K +10.8% 01 Oct 2012 31 Dec 2012 10-K 17 Mar 2014
Q3 2012 -$10.1M -$2.08M +$1.04M +33.4% 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013
Q2 2012 -$11.2M -$2.43M +$433K +15.2% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2013
Q1 2012 -$11.6M -$2.72M -$250K -10.1% 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013
Q4 2011 -$11.4M -$2.91M 01 Oct 2011 31 Dec 2011 10-K 26 Mar 2013
Q3 2011 -$3.12M -$182K -6.19% 01 Jul 2011 30 Sep 2011 10-Q 08 Nov 2012
Q2 2011 -$2.86M -$5.6K -0.2% 01 Apr 2011 30 Jun 2011 10-Q 08 Aug 2012
Q1 2011 -$2.47M 01 Jan 2011 31 Mar 2011 10-Q 14 May 2012
Q3 2010 -$2.94M 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 -$2.85M 01 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011

International Stem Cell CORP Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$68K +$595K +89.7% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025
2023 -$663K -$480K -262% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025
2022 -$183K +$1.74M +90.5% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 -$1.92M +$897K +31.8% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 -$2.82M +$2.91M +50.8% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022
2019 -$5.73M -$2.25M -64.9% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021
2018 -$3.47M +$1.47M +29.7% 01 Jan 2018 31 Dec 2018 10-K 01 Jun 2020
2017 -$4.94M -$91K -1.88% 01 Jan 2017 31 Dec 2017 10-K 15 Apr 2019
2016 -$4.85M -$287K -6.29% 01 Jan 2016 31 Dec 2016 10-K 09 Apr 2018
2015 -$4.56M +$4.12M +47.4% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017
2014 -$8.68M -$1.13M -15% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016
2013 -$7.55M +$2.27M +23.1% 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2015
2012 -$9.82M +$1.54M +13.6% 01 Jan 2012 31 Dec 2012 10-K 17 Mar 2014
2011 -$11.4M -$893K -8.54% 01 Jan 2011 31 Dec 2011 10-K 26 Mar 2013
2010 -$10.5M 01 Jan 2010 31 Dec 2010 10-K 16 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.